922 results on '"Pablo A Ortiz"'
Search Results
202. Principled labour law: U.S. labour law through a Latin American method, de Sergio Gamonal C. y César F. Rosado Marzán
- Author
-
Pablo Arellano Ortiz
- Subjects
Immunology - Published
- 2020
- Full Text
- View/download PDF
203. 17β-estradiol-induced mitochondrial dysfunction and Warburg effect in cervical cancer cells allow cell survival under metabolic stress
- Author
-
Raúl Solís‑Martínez, Luis Felipe Jave Suarez, Ana Laura Pereira‑Suárez, Annie Riera Leal, Adrián Ramírez De Arellano, Yveth Marlene Ortiz‑García, Carlos Alfredo Barrón‑Gallardo, Sonia Luquin De Anda, Pablo César Ortiz Lazareno, José Francisco Muñoz Valle, and Adriana Aguilar Lemarroy
- Subjects
0301 basic medicine ,Cancer Research ,antioxidant ,Membrane permeability ,Uterine Cervical Neoplasms ,Apoptosis ,Oxidative phosphorylation ,Mitochondrion ,Pentose phosphate pathway ,Oxidative Phosphorylation ,HeLa ,03 medical and health sciences ,0302 clinical medicine ,mitochondrial function ,Stress, Physiological ,Tumor Cells, Cultured ,Humans ,Glycolysis ,Cell Proliferation ,biology ,Estradiol ,Estrogens ,Articles ,biology.organism_classification ,Warburg effect ,Cell biology ,Mitochondria ,Ferritin ,030104 developmental biology ,Glucose ,Oncology ,030220 oncology & carcinogenesis ,biology.protein ,Female ,Energy Metabolism ,Reactive Oxygen Species ,Signal Transduction - Abstract
Mitochondria from different types of cancer show bioenergetics and dysfunction that favor cell proliferation. The mechanistic understanding of estrogen in cervical cancer is poorly understood. Therefore, the objective of this study was to determine how 17β‑estradiol (E2) affects mitochondrial function and the Warburg effect in SiHa, HeLa and C33A cervical cancer cells. Mitochondrial compromise was evaluated measuring changes in the membrane permeability by immunofluorescence, calcium concentration, redox status, iron and ferritin reserves. Glucose consumption and lactic acid assays were used to detect the metabolic activity. Results were confirmed at molecular level by analysis of the differential gene expression using RNA sequencing. E2 modified the mitochondrial permeability and produced an alteration in the calcium signaling pathway. In HeLa and SiHa, there was a significant decrease in nitric oxide levels and lipid peroxidation, and an increase in glucose consumption and lactic acid levels when stimulated with E2. Intracellular iron or ferritin reserves were not affected by the E2 treatment. Genes differentially modulated by E2 were involved in the mitochondrial electron transport chain, oxidative phosphorylation system, glycolysis, pentose phosphate pathway and the regulation of metabolic signaling pathways. Herein, we provide evidence for a primary effect of estrogen on mitochondrial function and the Warburg effect, favoring the metabolic adaptation of the cervical cancer cell lines and their survival.
- Published
- 2019
204. Quantitative morphological characters of the skull suggest that Akodon oenos (Rodentia, Cricetidae, Sigmodontinae) is not a junior synonym of A. spegazzinii
- Author
-
Ricardo A. Ojeda, J. Pablo Jayat, Agustina A. Ojeda, Agustina Novillo, Pablo Teta, Guillermo D’Elía, and Pablo E. Ortiz
- Subjects
0106 biological sciences ,0303 health sciences ,Sigmodontinae ,Akodon spegazzinii ,Zoology ,Biology ,biology.organism_classification ,010603 evolutionary biology ,01 natural sciences ,Akodon ,03 medical and health sciences ,Monophyly ,Animal Science and Zoology ,Type locality ,Akodon boliviensis ,Clade ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology ,Cricetidae - Abstract
Akodon oenos, a nominal form with type locality in northern Mendoza province, Argentina, has an intricate taxonomic history. Recently, it was considered a junior synonym of Akodon spegazzinii on the basis of morphological similarities of one individual captured in southern Mendoza with specimens belonging to the type series of A. oenos, plus the genetic similarity of that single specimen with representatives of A. spegazzinii. We compared specimens of the Akodon boliviensis species group recently captured in Mendoza with the type series of A. oenos and series of A. spegazzinii from northwestern Argentina. We conducted an analysis of molecular markers (cytochrome-b gene) and quantitative morphological studies (comparisons of skull measurements). Our results showed that: (1) all sequenced specimens of the A. boliviensis group from Mendoza form a monophyletic clade closely related to A. spegazzinii; (2) contrary to previous hypothesis, specimens of Akodon from Mendoza are morphologically distinctive in size and shape of the skull, from A. spegazzinii; and (3) within the A. boliviensis species group, specimens from Mendoza are distinctive. We argue that the synonymy of A. oenos under A. spegazzinii must await further studies, including molecular markers other than mitochondrial and samples of DNA sequences from topotypical specimens of A. oenos.
- Published
- 2019
- Full Text
- View/download PDF
205. Effect of diazinon, an organophosphate pesticide, on signal transduction and death induction in mononuclear cells of Nile tilapia fish (Oreochromis niloticus)
- Author
-
K.J.G. Díaz-Resendiz, G.H. Ventura-Ramón, Pablo C Ortiz-Lazareno, C.E. Covantes-Rosales, Manuel Iván Girón-Pérez, A.M. Trujillo-Lepe, and G.A. Toledo-Ibarra
- Subjects
Male ,0301 basic medicine ,Insecticides ,Diazinon ,MAP Kinase Signaling System ,Apoptosis ,Aquatic Science ,Biology ,Pharmacology ,03 medical and health sciences ,chemistry.chemical_compound ,Nile tilapia ,Immune system ,Leukocytes ,Animals ,Environmental Chemistry ,Phosphorylation ,Cellular Senescence ,Membrane Potential, Mitochondrial ,Organophosphate ,Cichlids ,04 agricultural and veterinary sciences ,General Medicine ,Pesticide ,biology.organism_classification ,Acetylcholinesterase ,Oreochromis ,030104 developmental biology ,chemistry ,040102 fisheries ,0401 agriculture, forestry, and fisheries ,Calcium ,Signal transduction ,Spleen ,Water Pollutants, Chemical ,Signal Transduction - Abstract
Diazinon (DZN) is an organophosphate pesticide characterized by inhibiting the enzyme acetylcholinesterase (AChE) (E.C. 3.1.1.7), affecting the nervous system. There is currently enough evidence proving this pesticide also affects the immune response; however, the immunotoxicity mechanisms through which these substances exerts toxic effects remain unclear. For that reason, this work evaluated the effect of diazinon on the intracellular calcium flux, ERK1/2 phosphorylation (pERK1/2), apoptosis, senescence, and mitochondrial membrane potential (ΔΨm) in spleen mononuclear cells (SMNC) of Nile tilapia, a teleost fish of commercial and ecological relevance. The results obtained indicate that diazinon causes significant damage in all evaluated parameters, which play an essential role in intracytoplasmic signaling of immune cells, suggesting these signal pathways could be related with the immunotoxicity mechanism of these type of pesticides.
- Published
- 2019
- Full Text
- View/download PDF
206. Positive/retained SDHB immunostaining in renal cell carcinomas associated to germline SDHB-deficiency: case report
- Author
-
Raul Fernandez-Prado, Gabriela Rossello, Alberto Ortiz, Isabel Lorda, Pablo Cannata-Ortiz, Marina Ugarte-Camara, and Carmen González-Enguita
- Subjects
0301 basic medicine ,Adult ,Male ,Pathology ,medicine.medical_specialty ,Cytoplasm ,Histology ,SDHB ,Cell ,Case Report ,Biology ,Nephrectomy ,Germline ,Pathology and Forensic Medicine ,03 medical and health sciences ,0302 clinical medicine ,Germline mutation ,Renal cell carcinoma ,medicine ,lcsh:Pathology ,Humans ,Hereditary renal cancer ,Carcinoma, Renal Cell ,Germ-Line Mutation ,Clear cell carcinoma ,General Medicine ,medicine.disease ,Immunohistochemistry ,Succinate dehydrogenase, PGL4 syndrome ,Kidney Neoplasms ,Succinate Dehydrogenase ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Immunostaining ,lcsh:RB1-214 - Abstract
Background According to WHO, succinate dehydrogenase (SDH)–deficient renal cell carcinoma is characterized by negative immunostaining for SDHB, which remains positive in non-tumor tissue despite germline mutations in the SDHB gene. We now report a patient with a SDHB mutation, c.166_170del (p.Pro56Tyrfs*5) who developed renal cell carcinomas with characteristic morphological features of SDH-deficient renal cell carcinoma but had positive SDHB immunostaining. Case presentation Within a 6-year period, the patient developed two different renal cell carcinomas, which had characteristic morphological features of SDH-deficient renal cell carcinoma (uniform cells characteristically displaying eosinophilic granular material intermixed with fewer cells exhibiting clear intracytoplasmic inclusions and bland centered nuclei) but displayed immunohistochemistry for SDHB with a cytoplasmic granular positivity (mitochondrial pattern) in tumor cells. For the second case, this was initially interpreted as positive by IHC, but on review some subtle differences were identified. Conclusions SDHB immunostaining may be positive in renal cell carcinoma associated to germline SDHB deficiency which have other typical morphological features. Immunohistochemistry interpretation may be complex. Electronic supplementary material The online version of this article (10.1186/s13000-019-0812-6) contains supplementary material, which is available to authorized users.
- Published
- 2019
- Full Text
- View/download PDF
207. A new nomenclatural system for the study of sigmodontine rodent molars: first step towards an integrative phylogeny of fossil and living cricetids
- Author
-
Franck Barbiere, Ulyses F. J. Pardiñas, Christophe Ronez, Pablo E. Ortiz, and Robert A. Martin
- Subjects
Rodent ,Evolutionary biology ,Phylogenetics ,biology.animal ,Biology ,Ecology, Evolution, Behavior and Systematics - Published
- 2019
- Full Text
- View/download PDF
208. Use of extracellular vesicles from lymphatic drainage as surrogate markers of melanoma progression and BRAFV600E mutation
- Author
-
Alberto Hernández-Barranco, Kay Brinkmann, Sara Sánchez-Redondo, Mary Sue Brady, Carlos F. Rodríguez, Cristina Montero, Rocío Letón, Laura Nogués, Héctor Peinado, Carmen García-Martín, Ana Amor López, Jasminka Boskovic, Lisa Meyer, Pablo L. Ortiz-Romero, Mikkel Noerholm, Piotr Rutkowski, Pilar Ximénez-Embún, Anna Szumera-Ciećkiewicz, Yolanda Ruano, Marina S. Mazariegos, Mercedes Robledo, Alberto Benito-Martin, Johan Skog, Susana García-Silva, Iwona Kalinowska, José Luis Rodríguez-Peralto, Javier Muñoz, and Laura Santambrogio
- Subjects
0301 basic medicine ,medicine.medical_treatment ,Immunology ,medicine.disease_cause ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Immunology and Allergy ,neoplasms ,Research Articles ,Mutation ,business.industry ,Melanoma ,Brief Definitive Report ,Cancer ,medicine.disease ,Microvesicles ,3. Good health ,030104 developmental biology ,Lymphatic system ,Tumor progression ,030220 oncology & carcinogenesis ,Seroma ,Cancer research ,Lymphadenectomy ,business - Abstract
García-Silva et al. show for the first time that extracellular vesicles isolated from the exudative seroma obtained from the lymphatic drainage implanted in melanoma patients after lymphadenectomy can be interrogated for melanoma markers and BRAF mutations. Profiling the BRAFV600E mutation in this biofluid is a novel approach to predict disease relapse., Liquid biopsies from cancer patients have the potential to improve diagnosis and prognosis. The assessment of surrogate markers of tumor progression in circulating extracellular vesicles could be a powerful non-invasive approach in this setting. We have characterized extracellular vesicles purified from the lymphatic drainage also known as exudative seroma (ES) of stage III melanoma patients obtained after lymphadenectomy. Proteomic analysis showed that seroma-derived exosomes are enriched in proteins resembling melanoma progression. In addition, we found that the BRAFV600E mutation can be detected in ES-derived extracellular vesicles and its detection correlated with patients at risk of relapse., Graphical Abstract
- Published
- 2019
209. The Illiberal Abuse of Constitutional Courts in Europe
- Author
-
Pablo Castillo-Ortiz
- Subjects
050502 law ,Power (social and political) ,Politics ,Leverage (negotiation) ,restrict ,Political science ,05 social sciences ,050602 political science & public administration ,Constitutionalism ,Law ,0505 law ,0506 political science ,Law and economics - Abstract
Legal constitutionalism – Political constitutionalism – Emergence of illiberal constitutionalism as a tertium genus – Examination of constitutional courts under three illiberal governments: Poland, Hungary, and Turkey – Illiberal governments’ strategies to seize control of constitutional courts – Illiberal governments’ aim to secure leverage over constitutional judges and restrict the powers of review of the court – Constitutional courts under illiberal rule invert the traditional functions that were assigned to them under the original Kelsenian approach – Instead of a check on power, illiberal constitutional courts become a device to circumvent constitutional constraints and concentrate power in the hands of the ruling actors.
- Published
- 2019
- Full Text
- View/download PDF
210. Constitutional courts and citizens’ perceptions of judicial systems in Europe
- Author
-
Pablo Castillo-Ortiz and Rosa M. Navarrete
- Subjects
Human rights ,Constitution ,media_common.quotation_subject ,05 social sciences ,Comparative politics ,Judicial independence ,050601 international relations ,Democracy ,0506 political science ,Rule of law ,Politics ,Political science ,Political Science and International Relations ,050602 political science & public administration ,Constitutional review ,Law and economics ,media_common - Abstract
In recent decades, constitutional courts have become essential institutions in the political systems of many European countries. At the legal level, constitutional courts are designed as organs intended to protect and enforce the normative constitution. At the political level, they are also expected to play a role in the protection of democratic systems of government and human rights. However, the stability of a democracy does not only depend on efficient institutional designs, but also on acceptable levels of public support for democratic institutions. Using data from the European Social Survey, this article shows that constitutional courts have negative effects on public views of the court system in at least two dimensions: perceptions of judicial independence and perceptions of judicial fairness. These effects, however, decrease with the age of the democratic system. Given the core role that diffuse support for the judiciary plays in the stability of the rule of law in a country, our findings suggest that, paradoxically, constitutional courts might have detrimental effects to the very goal that justifies their existence: the protection of democratic systems of government.
- Published
- 2019
- Full Text
- View/download PDF
211. Is cyclosporine a good option for the treatment of subcutaneous panniculitis-like T-cell lymphoma associated with hemophagocytic syndrome?
- Author
-
Maria C. Garrido, Raquel Aragón-Miguel, Virginia Velasco-Tamariz, Lidia Maroñas-Jiménez, Pablo L. Ortiz-Romero, and Alba Calleja-Algarra
- Subjects
medicine.medical_specialty ,Infectious Diseases ,business.industry ,Subcutaneous Panniculitis-Like T-Cell Lymphoma ,lcsh:Dermatology ,Medicine ,Dermatology ,lcsh:RL1-803 ,business ,medicine.disease ,Lymphoma - Published
- 2019
212. Low-dose endosulfan inhibits proliferation and induces senescence and pro-inflammatory cytokine production in human lymphocytes, preferentially impacting cytotoxic cells
- Author
-
Jaime Gómez-Villela, Jesse Haramati, Pablo C Ortiz-Lazareno, Martha Cecilia Tellez-Bañuelos, Salvador González-Ochoa, and Vida Celeste Rosas-Gonzalez
- Subjects
Male ,endosulfan ,Insecticides ,senescence ,medicine.medical_treatment ,010501 environmental sciences ,Toxicology ,01 natural sciences ,chemistry.chemical_compound ,Interferon ,Cytotoxic T cell ,nk cells ,cytotoxic cells ,Cells, Cultured ,Cellular Senescence ,organochlorine pesticide ,immunosenescence ,0303 health sciences ,B-Lymphocytes ,Immunosenescence ,interferon ,Contamination ,Healthy Volunteers ,Killer Cells, Natural ,Cytokine ,Cytokines ,Female ,Inflammation Mediators ,medicine.drug ,Senescence ,Adult ,lcsh:Immunologic diseases. Allergy ,Immunology ,Primary Cell Culture ,Peripheral blood mononuclear cell ,03 medical and health sciences ,Young Adult ,lcsh:RA1190-1270 ,parasitic diseases ,medicine ,pbmc ,Humans ,Endosulfan ,030304 developmental biology ,0105 earth and related environmental sciences ,Cell Proliferation ,lcsh:Toxicology. Poisons ,Dose-Response Relationship, Drug ,chemistry ,Cancer research ,lcsh:RC581-607 ,T-Lymphocytes, Cytotoxic - Abstract
Endosulfan is a DDT-era organochlorine pesticide. Due to past and current environmental contamination, investigation of endosulfan exposure is of current importance. Acute high dose exposure precipitates neural/endocrine system damage, but the effects on the immune system and of lower doses are not well-characterized. Two relatively low concentrations of endosulfan (i.e. 0.1 and 17 µM ENDO) were investigated in an in vitro study using human peripheral blood mononuclear cells (PBMC) to understand effects of relatively low doses (0.1–25.0 µM [≈0.04–10 ppm/40–10,000 ppb]) of ENDO upon normal human T- and B-lymphocytes and NK cells. The study here found that 17 µM ENDO inhibited phytohemagglutinin-M (PHA)-induced human PBMC proliferation. It was also seen that senescence and apoptosis among non-stimulated cells was increased, specifically within CD8 and NK populations, and that CD4:CD8 ratios also were increased. Treatment of non-stimulated PBMC with ENDO led to overall increases in production of tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-2, -4, and -6, and decreased production of anti-inflammatory IL-10, suggesting an immunosenescence secretory phenotype. Interestingly, when the cells were pre-stimulated with mitogen (PHA), ENDO became inhibitory against the mitogen-induced proliferation and cytokine formation – with the exception of that of TNFα and IL-6, suggesting differential effects of ENDO on activated cells. Thus, at the organismal level, ENDO might also display differential effects during states of autoimmune disease or chronic viral infection in the exposed host.
- Published
- 2019
213. Synthesis and characterization of processable fluorinated aromatic poly(benzamide imide)s derived from cycloalkane substituted diamines, and their application in a computationally driven synthesis methodology
- Author
-
Deysma Coll, Luis H. Tagle, Pablo A. Ortiz, Claudio A. Terraza, Darío M. González, German Perez, Alain Tundidor-Camba, and Manuel Aguilar-Vega
- Subjects
chemistry.chemical_classification ,Chemical resistance ,Condensation polymer ,Materials science ,Polymers and Plastics ,Organic Chemistry ,02 engineering and technology ,Polymer ,Permeation ,010402 general chemistry ,021001 nanoscience & nanotechnology ,01 natural sciences ,Combinatorial chemistry ,0104 chemical sciences ,chemistry.chemical_compound ,Cycloalkane ,chemistry ,Materials Chemistry ,Thermal stability ,Solubility ,0210 nano-technology ,Imide - Abstract
A new set of four fluorinated aromatic poly(benzamide imide)s was synthesized with the objective of preparing condensation polymers with good processability while maintaining high chemical resistance, thermal stability and good mechanical properties. Their synthesis was carried out using commercially available cycloalkane substituted diamines, 3,5-dinitrbenzoyl chloride and 4,4'-(hexafluoroisopropylidene)diphthalic anhydride (6FDA) as starting materials. The research was focused on the influence of pendant groups and the testing of a computational methodology that could help to predict polymer properties based on their structure and available QSPR models. To this end, extensive tests were performed on these new poly(imide)s including, IR, NMR, X-ray diffraction, UV absorption, thermal stability, mechanical tests, gas permeation and solubility analyses. The results showed that the materials obtained present properties similar to many available commercial poly(imide)s. On the other hand, computational simulations demonstrated that the strategy followed could be useful in reducing the number of compounds to be synthesized and at the same time, maximize the success ratio of finding polymers with certain desired properties.
- Published
- 2019
- Full Text
- View/download PDF
214. migrantes a desamparados. Estudio de los migrantes indocumentados en la frontera Petén-Tabasco
- Author
-
Juan Pablo Bolio Ortiz, Kiry Rebeca Vences Solis, and Héctor Joaquín Bolio Ortiz
- Subjects
Human rights ,derechos ,media_common.quotation_subject ,Migración ,Perspective (graphical) ,Vulnerability ,Centroamérica ,General Medicine ,lcsh:History of scholarship and learning. The humanities ,Economic situation ,Political science ,lcsh:AZ20-999 ,Ethnology ,lcsh:H1-99 ,Central american ,lcsh:Social sciences (General) ,lcsh:Science (General) ,lcsh:Q1-390 ,media_common - Abstract
El presente artículo presenta la situación de los migrantes centroamericanos hacia México y los Estados Unidos. El estudio se centra en el caso de la frontera Petén- Tabasco, bajo la perspectiva de los Derechos Humanos y a través del trabajo de campo, se constata la situación de vulnerabilidad en la que se encuentran los migrantes, quienes con el sueño de mejorar su situación económica terminan pasando por diversos obstáculos en su recorrido.
- Published
- 2019
- Full Text
- View/download PDF
215. Pentoxifylline Enhances the Apoptotic Effect of Carboplatin in Y79 Retinoblastoma Cells
- Author
-
Alejandro Bravo-Cuellar, Cristina Rodríguez-Padilla, Alejandro Bravo-Hernandez, Marı́a Martha Villaseñor-Garcı́a, Claudia Carolina Cruz-Galvez, Pablo C Ortiz-Lazareno, Emmanuel Reyes-Uribe, Martha Cancino-Marentes, Georgina Hernández-Flores, Raul Antonio Solis-Martinez, and Eliza Julia Pedraza-Brindis
- Subjects
endocrine system ,Cancer Research ,Cell Survival ,Apoptosis ,General Biochemistry, Genetics and Molecular Biology ,Carboplatin ,Pentoxifylline ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Cell Line, Tumor ,Antineoplastic Combined Chemotherapy Protocols ,medicine ,Humans ,Viability assay ,Phosphorylation ,Caspase ,Membrane Potential, Mitochondrial ,Pharmacology ,biology ,Retinoblastoma ,Chemistry ,Cytochrome c ,medicine.disease ,Neoplasm Proteins ,Gene Expression Regulation, Neoplastic ,030220 oncology & carcinogenesis ,Cancer research ,biology.protein ,Research Article ,medicine.drug - Abstract
Background/aim Retinoblastoma (RB) is the most common primary intraocular malignancy. Carboplatin (CPt) is a DNA damage-inducing agent that is widely used for the treatment of RB. Unfortunately, this drug also activates the transcription factor nuclear factor-kappa B (NF-ĸB), leading to promotion of tumor survival. Pentoxifylline (PTX) is a drug that inhibits the phosphorylation of I kappa B-alpha (IĸBα) in serines 32 and 36, and this disrupts NF-ĸB activity that promotes tumor survival. The goal of this study was to evaluate the effect of the PTX on the antitumor activity of CPt. Materials and methods Y79 RB cells were treated with CPt, PTX, or both. Cell viability, apoptosis, loss of mitochondrial membrane potential, the activity of caspase-9, -8, and -3, cytochrome c release, cell-cycle progression, p53, and phosphorylation of IĸBα, and pro- and anti-apoptotic genes were evaluated. Results Both drugs significantly affected the viability of the Y79 RB cells in a time- and dose-dependent manner. The PTX+CPt combination exhibited the highest rate of apoptosis, a decrease in cell viability and significant caspase activation, as well as loss of mitochondrial membrane potential, release of cytochrome c, and increased p53 protein levels. Cells treated with PTX alone displayed decreased I kappa B-alpha phosphorylation, compared to the CPt treated group. In addition, the PTX+CPt combination treatment induced up-regulation of the proapoptotic genes Bax, Bad, Bak, and caspases- 3, -8, and -9, compared to the CPt and PTX individual treated groups. Conclusion PTX induces apoptosis per se and increases the CPt-induced apoptosis, augmenting its antitumor effectiveness.
- Published
- 2019
- Full Text
- View/download PDF
216. Fully scalable video coding with packed stream.
- Author
-
Manuel F. López, Sebastian G. Rodríguez, Juan Pablo Garcia Ortiz, Jose Miguel Dana, Vicente González Ruiz, and Inmaculada García
- Published
- 2005
- Full Text
- View/download PDF
217. Financialization: The AIDS of economic system
- Author
-
Juan Pablo Durán Ortiz
- Subjects
La financiarización ,El SIDA ,El sistema económico ,Crisis ,Economic history and conditions ,HC10-1085 ,Economic theory. Demography ,HB1-3840 ,Economics as a science ,HB71-74 - Abstract
Epistemológicamente, el sistema económico puede ser entendido a través de dos enfoques: biología y física. En este trabajo, se utiliza el enfoque biológico para ilustrar la financialización, que es el proceso por el cual se reorientan todos los recursos económicos hacia el mercado especulativo. En este trabajo se compara el sistema económico con el cuerpo humano con el fin de estudiar la financiarización y sus efectos en el sistema económico. En particular, se explica cómo la financiarización se desarrolla en la economía de una manera similar a la forma como el SIDA se propaga dentro del cuerpo humano, tanto en la forma como crece dentro del sistema, como también por las consecuencias que genera dentro del mismo. Finalmente se proponen algunas acciones que pueden minimizar los riesgos de las crisis dentro de la economía partiendo de sus verdaderas causas.
- Published
- 2014
218. Sobre Óscar Mazín (ed.), Las representaciones del poder en las sociedades hispánicas
- Author
-
Juan Pablo Bolio Ortiz
- Subjects
Mazín ,poder ,representaciones ,España ,History America ,E-F ,Latin America. Spanish America ,F1201-3799 - Published
- 2014
219. PIM kinases as potential therapeutic targets in a subset of peripheral T cell lymphoma cases.
- Author
-
Esperanza Martín-Sánchez, Lina Odqvist, Socorro M Rodríguez-Pinilla, Margarita Sánchez-Beato, Giovanna Roncador, Beatriz Domínguez-González, Carmen Blanco-Aparicio, Ana M García Collazo, Esther González Cantalapiedra, Joaquín Pastor Fernández, Soraya Curiel del Olmo, Helena Pisonero, Rebeca Madureira, Carmen Almaraz, Manuela Mollejo, F Javier Alves, Javier Menárguez, Fernando González-Palacios, José Luis Rodríguez-Peralto, Pablo L Ortiz-Romero, Francisco X Real, Juan F García, James R Bischoff, and Miguel A Piris
- Subjects
Medicine ,Science - Abstract
Currently, there is no efficient therapy for patients with peripheral T cell lymphoma (PTCL). The Proviral Integration site of Moloney murine leukemia virus (PIM) kinases are important mediators of cell survival. We aimed to determine the therapeutic value of PIM kinases because they are overexpressed in PTCL patients, T cell lines and primary tumoral T cells. PIM kinases were inhibited genetically (using small interfering and short hairpin RNAs) and pharmacologically (mainly with the pan-PIM inhibitor (PIMi) ETP-39010) in a panel of 8 PTCL cell lines. Effects on cell viability, apoptosis, cell cycle, key proteins and gene expression were evaluated. Individual inhibition of each of the PIM genes did not affect PTCL cell survival, partially because of a compensatory mechanism among the three PIM genes. In contrast, pharmacological inhibition of all PIM kinases strongly induced apoptosis in all PTCL cell lines, without cell cycle arrest, in part through the induction of DNA damage. Therefore, pan-PIMi synergized with Cisplatin. Importantly, pharmacological inhibition of PIM reduced primary tumoral T cell viability without affecting normal T cells ex vivo. Since anaplastic large cell lymphoma (ALK+ ALCL) cell lines were the most sensitive to the pan-PIMi, we tested the simultaneous inhibition of ALK and PIM kinases and found a strong synergistic effect in ALK+ ALCL cell lines. Our findings suggest that PIM kinase inhibition could be of therapeutic value in a subset of PTCL, especially when combined with ALK inhibitors, and might be clinically beneficial in ALK+ ALCL.
- Published
- 2014
- Full Text
- View/download PDF
220. Lymphomatoid papulosis mimicking distal embolism
- Author
-
Concepción Postigo-Llorente, Jon Fulgencio-Barbarin, and Pablo Luis Ortiz Romero
- Subjects
medicine.medical_specialty ,Skin Neoplasms ,business.industry ,Embolism ,Dermatology ,medicine.disease ,Hodgkin Disease ,Lymphomatoid Papulosis ,Medicine ,Humans ,Lymphomatoid papulosis ,business - Published
- 2021
221. Novel Polyelectrolytes Obtained by Direct Alkylation and Ion Replacement of a New Aromatic Polyamide Copolymer Bearing Pyridinyl Pendant Groups
- Author
-
Pablo A. Ortiz, Sebastián Bonardd, Alain Tundidor-Camba, Alejandro Ángel, Deysma Coll, and Ángel Norambuena
- Subjects
Thermogravimetric analysis ,Materials science ,Polymers and Plastics ,Inorganic chemistry ,Infrared spectroscopy ,Organic chemistry ,02 engineering and technology ,010402 general chemistry ,01 natural sciences ,Article ,Differential scanning calorimetry ,QD241-441 ,pyridinyl groups ,Solubility ,quaternisation ,polyelectrolyte ,chemistry.chemical_classification ,polyamide ,General Chemistry ,Polymer ,021001 nanoscience & nanotechnology ,Polyelectrolyte ,0104 chemical sciences ,chemistry ,Polyamide ,0210 nano-technology ,Glass transition - Abstract
The following work shows, for the first time, the synthesis and characterization of a new family of polyelectrolytes, along with their preliminary assessments in terms of desalin water treatment. These materials fall into the category of aromatic co-polyamides, which are obtained by the direct condensation of monomers 4,4′-oxydianiline (ODA), isophthaloyl chloride, and 3,5-diamino-N-(pyridin-4-ylmethyl)benzamide (PyMDA). Thereby, the charged nature exhibited by these materials was achieved through the quaternization of PyMDA moieties using linear iodoalkanes of different lengths (CnI with n = 1, 2, 4, and 6). After completing the quaternization process, polyelectrolytes were subjected to a one-step anion substitution process, where iodide counterions were replaced by bis(trifluoromethane)sulfonamide entities. For all the obtained materials, solubility tests were carried out, showing that those alkylated with methyl and ethyl chains exhibit high solubility in rutinary aprotic polar solvents, while those containing n-butyl and n-hexyl units resulted in the formation of insoluble gels. Due to the above, the latest were discarded from this study early on. The structural characterization of the initial neutral co-polyamide was carried out by means of infrared spectroscopy (FT-IR), nuclear magnetic resonance (1H, 13C-NMR), and size-exclusion chromatography (SEC), while the structure of methylated and ethylated polyelectrolytes was successfully confirmed through FT-IR, 1H, 13C, and 19F-NMR. Additionally, the thermal behavior of these materials was analyzed in terms of thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC), showing thermal degradation temperatures above 300 °C and glass transition temperatures (Tg) above 200 °C, resulting in polymers with outstanding thermal properties for water treatment applications. On the other hand, through the solvent-casting method, both neutral and charged polymers were found to be easily prepared into films, exhibiting a remarkably flexibility. The mechanical properties of the films were analyzed using the traction test, from which tensile strength values ranging between 83.5 and 87.9 Mpa, along with Young’s modulus values between 2.4 and 2.5 Gpa were obtained. Moreover, through contact angle measurements and absorption analysis by immersion, polyelectrolytes showed important changes in terms of affinity against polar and polar substances (water, n-heptane, and benzene), exhibiting a higher rejection regarding the neutral polymer. Finally, as a preliminary test against the seepage of saline waters, thin polymer films (from 11.4 to 17.1 µm) were deposited on top of commercial filter discs and tested as filters of saline solutions ([NaCl] = 1000 and 2000 ppm). These tests revealed a decrease of the salt concentration in the obtained filtrates, with retention values ranging between 6.2 and 20.3%, depending on the concentration of the former solution and the polymer used.
- Published
- 2021
- Full Text
- View/download PDF
222. PGC-1α deficiency causes spontaneous kidney inflammation and increases the severity of nephrotoxic AKI
- Author
-
Carmen Gonzalez Enguita, Diego Martin Sanchez, Ramiro Cabello, Irsin, Reyes católicos Ave, Madrid , Spain., Pablo Cannata Ortiz, Julio Manuel Martínez Moreno, Redinren, Reyes católicos Ave, Madrid , Spain., Susana Carrasco, Manuel Gómez, Maria Dolores Sanchez Niño, Miguel Fontecha Barriuso, María Monsalve, Olga Ruiz-Andres, Ana Belen Sanz, Marta Ruiz Ortega, Cristina Sánchez-Ramos, and Alberto Ortiz
- Subjects
medicine.medical_specialty ,Endocrinology ,business.industry ,Internal medicine ,medicine ,Kidney inflammation ,business ,Nephrotoxicity - Published
- 2021
- Full Text
- View/download PDF
223. New radiometric 40Ar–39Ar dates and faunistic analyses refine evolutionary dynamics of Neogene vertebrate assemblages in southern South America
- Author
-
M. Carolina Madozzo Jaén, Gabriela Ines Schmidt, Matias Taglioretti, Ulyses F. J. Pardiñas, Sidney R. Hemming, Ricardo Adolfo Bonini, Pablo E. Ortiz, Luciano Luis Rasia, Adriana Magdalena Candela, Esperanza Cerdeño, François Pujos, Francisco Juan Prevosti, Cristo O. Romano, Ross D. E. MacPhee, and Analía M. Forasiepi
- Subjects
010506 paleontology ,Fauna ,Science ,Argentina ,010502 geochemistry & geophysics ,Neogene ,01 natural sciences ,Article ,purl.org/becyt/ford/1 [https] ,Paleontology ,purl.org/becyt/ford/1.5 [https] ,Abundance (ecology) ,Radiometric 40Ar-39Ar dates ,biology.animal ,Animals ,Vertebrate paleontology ,Argon ,Evolutionary dynamics ,0105 earth and related environmental sciences ,Radioisotopes ,Multidisciplinary ,biology ,Fossils ,Palaeontology ,Vertebrate ,Biodiversity ,South America ,Biological Evolution ,Geography ,Taxon ,Vertebrates ,Medicine ,Radiometric dating ,Mammalian fauna - Abstract
The vertebrate fossil record of the Pampean Region of Argentina occupies an important place in South American vertebrate paleontology. An abundance of localities has long been the main basis for constructing the chronostratigraphical/geochronological scale for the late Neogene–Quaternary of South America, as well as for understanding major patterns of vertebrate evolution, including the Great American Biotic Interchange. However, few independently-derived dates are available for constraining this record. In this contribution, we present new 40Ar/39Ar dates on escorias (likely the product of meteoric impacts) from the Argentinean Atlantic coast and statistically-based biochronological analyses that help to calibrate Late Miocene–Pliocene Pampean faunal successions. For the type areas of the Montehermosan and Chapadmalalan Ages/Stages, our results delimit their age ranges to 4.7–3.7 Ma and ca. 3.74–3.04 Ma, respectively. Additionally, from Buenos Aires Province, dates of 5.17 Ma and 4.33 Ma were recovered for “Huayquerian” and Montehermosan faunas. This information helps to better calibrate important first appearances of allochthonous taxa in South America, including one of the oldest records for procyonids (7.24–5.95 Ma), cricetids (6.95–5.46 Ma), and tayassuids (> 3.74 Ma, oldest high-confidence record). These results also constrain to ca. 3 Ma the last appearances of the autochthonous sparassodonts, as well as terror birds of large/middle body size in South America. South American faunal turnover during the late Neogene, including Late Pliocene extinctions, is interpreted as a consequence of knock-on effects from global climatic changes and initiation of the icehouse climate regime. Fil: Prevosti, Francisco Juan. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de la Rioja. Secretaria de Ciencia y Tecnología; Argentina Fil: Romano Muñoz, Cristo Omar. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Provincia de Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Universidad Nacional de Cuyo. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales; Argentina Fil: Forasiepi, Analia Marta. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Provincia de Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Universidad Nacional de Cuyo. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales; Argentina Fil: Hemming, Sidney. Columbia University; Estados Unidos Fil: Bonini, Ricardo Adolfo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tandil. Investigaciones Arqueológicas y Paleontológicas del Cuaternario Pampeano. Universidad Nacional del Centro de la Provincia de Buenos Aires. Investigaciones Arqueológicas y Paleontológicas del Cuaternario Pampeano; Argentina Fil: Candela, Adriana Magdalena. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo. División Paleontología Vertebrados; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina Fil: Cerdeño Serrano, Maria Esperanza. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Provincia de Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Universidad Nacional de Cuyo. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales; Argentina Fil: Madozzo Jaén, María Carolina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Correlación Geológica. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo. Departamento de Geología. Cátedra Geología Estructural. Instituto Superior de Correlación Geológica; Argentina. Museo Paleontológico Egidio Feruglio; Argentina Fil: Ortiz, Pablo Edmundo. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Tucumán. Instituto Superior de Correlación Geológica. Universidad Nacional de Tucumán. Facultad de Ciencias Naturales e Instituto Miguel Lillo. Departamento de Geología. Cátedra Geología Estructural. Instituto Superior de Correlación Geológica; Argentina Fil: Pujos, François Roger Francis. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Provincia de Mendoza. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales. Universidad Nacional de Cuyo. Instituto Argentino de Nivología, Glaciología y Ciencias Ambientales; Argentina Fil: Rasia, Luciano Luis. Universidad Nacional de La Plata. Facultad de Ciencias Naturales y Museo. División Paleontología Vertebrados; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - La Plata; Argentina Fil: Schmidt, Gabriela Ines. Provincia de Entre Ríos. Centro de Investigaciones Científicas y Transferencia de Tecnología a la Producción. Universidad Autónoma de Entre Ríos. Centro de Investigaciones Científicas y Transferencia de Tecnología a la Producción. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe. Centro de Investigaciones Científicas y Transferencia de Tecnología a la Producción; Argentina Fil: Taglioretti, Matias Luciano. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de Mar del Plata. Facultad de Ciencias Exactas y Naturales. Instituto de Geología de Costas y del Cuaternario. Provincia de Buenos Aires. Gobernación. Comisión de Investigaciones Científicas. Instituto de Geología de Costas y del Cuaternario; Argentina. Litoral Atlántico Norte. Observatorio Patrimonio Arqueológico y Paleontológico; Argentina Fil: Macphee, Ross Douglas Earle. American Museum of Natural History; Estados Unidos Fil: Pardiñas, Ulises Francisco J.. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Centro Nacional Patagónico. Instituto de Diversidad y Evolución Austral; Argentina. Instituto Nacional de Biodiversidad; Ecuador
- Published
- 2021
224. Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial
- Author
-
Christoph Hoeller, Marie-Francoise Avril, Pietro Quaglino, François Aubin, Lars Bastholt, Takashi Inozume, Virginia Ferraresi, Michael B. Jameson, Kevin B. Kim, Oliver Bechter, Dirk Schadendorf, Kenji Yokota, Carmen Loquai, Maria-Jose Passos, Inge Marie Svane, Michele Maio, Catherine Barrow, Frank Meiss, Nageatte Ibrahim, Andrzej Mackiewicz, Phillip Parente, Tatsuya Takenouchi, Caroline Dutriaux, Piotr Rutkowski, Alfonsus J M van den Eertwegh, Paola Queirolo, Catriona M. McNeil, Peter Mohr, Felix Kiecker, Susana Puig, Friedegund Meier, Lutz Kretschmer, Alexander C.J. van Akkooi, Alex Menzies, Timothy Crook, Christian U. Blank, Suzana Matkovic, Michael C. Brown, Ragini R. Kudchadkar, Max Levin, Rüdiger Hein, Tanja Skytta, Gerald P. Linette, Clemens Krepler, Adnan Khattak, Ernest Marshall, Joseph Kerger, Oddbjorn Straume, Laurent Mortier, Jochen Utikal, Micaela Hernberg, James Larkin, Yoshio Kiyohara, Mario Mandalà, Henrik Schmidt, Daniil Stroyakovskiy, Pablo Luis Ortiz Romero, Naoya Yamazaki, John Walker, Anna Maria Di Giacomo, Lionel Geoffrois, Jean-Philippe Lacour, Caroline Robert, Vincent Descamps, Shahneen Sandhu, Gil Bar-Sela, Paul C. Nathan, Marcin Dzienis, Ralf Gutzmer, Claus Garbe, Andrey Meshcheryakov, Patrick Combemale, Martin Fehr, Guzel Mukhametshina, Helena Kapiteijn, Geke A. P. Hospers, Jun Aoi, Andrew Haydon, Rutger H. T. Koornstra, Marie-Thérèse Leccia, Sigrun Hallmeyer, Pier Francesco Ferrucci, Jean-Jacques Grob, Leonel Hernandez-Aya, Jan-Christoph Simon, Vanna Chiarion Sileni, Alain Algazi, Lidija Sekulovic, Sandrine Marreaud, Bernard Fitzharris, Jacob Schachter, Xinni Song, Wolf-Henning Boehncke, Rahima Jamal, Paul Lorigan, Maureen J.B. Aarts, Reinhard Dummer, Mike McCrystal, César Martins, Reiner Hofmann-Wellenhof, Alexander M.M. Eggermont, Carola Berking, Elaine Dunwoodie, Bernard Guillot, Michal Kicinski, Philippe Saiag, Céleste Lebbé, Thierry Lesimple, Stefan Suciu, Michal Lotem, Paula Ferreira, Mohammed M. Milhem, Laurent Machet, Patrick Terheyden, Anna Katharina Winge-Main, Peter Hersey, Jean-Francois Baurain, Axel Hauschild, Stéphane Dalle, Jean-Philippe Arnault, Paolo A. Ascierto, Gerard Groenewegen, Florent Grange, Georgina V. Long, Victoria Atkinson, Philippa Corrie, Matteo S. Carlino, Thomas Jouary, Daniel Hendler, Richard Casasola, Ashita Waterston, Jessica C. Hassel, University Medical Center [Utrecht], Azienda Ospedaliera Ospedale Papa Giovanni XXIII [Bergamo, Italy], The University of Sydney, Princess Alexandra Hospital, Brisbane, University of Queensland [Brisbane], Centre Léon Bérard [Lyon], Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), N.N. Blokhin National Medical Research Center of Oncology, Edith Cowan University (ECU), Royal Marsden NHS Foundation Trust, Universitat de Barcelona (UB), Instituto de Salud Carlos III [Madrid] (ISC), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), Universitätsklinikum Essen [Universität Duisburg-Essen] (Uniklinik Essen), Radboud University Medical Center [Nijmegen], Washington University School of Medicine in St. Louis, Washington University in Saint Louis (WUSTL), University Hospital of Siena, Amsterdam UMC - Amsterdam University Medical Center, Hôpital de la Timone [CHU - APHM] (TIMONE), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hannover Medical School [Hannover] (MHH), Centre Hospitalier de l'Université de Montréal (CHUM), Université de Montréal (UdeM), The Christie NHS Foundation Trust [Manchester, Royaume-Uni], Merck & Co. Inc, European Organisation for Research and Treatment of Cancer [Bruxelles] (EORTC), European Cancer Organisation [Bruxelles] (ECCO), Institut Gustave Roussy (IGR), Oncologie dermatologique, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Université de Montpellier (UM), Internal medicine, and CCA - Cancer Treatment and quality of life
- Subjects
Male ,Skin Neoplasms ,Medizin ,Pembrolizumab ,law.invention ,Cancer development and immune defence Radboud Institute for Health Sciences [Radboudumc 2] ,MESH: Aged, 80 and over ,0302 clinical medicine ,Randomized controlled trial ,law ,Monoclonal ,80 and over ,MESH: Double-Blind Method ,030212 general & internal medicine ,Neoplasm Metastasis ,Humanized ,Melanoma ,MESH: Aged ,Aged, 80 and over ,education.field_of_study ,MESH: Middle Aged ,Hazard ratio ,MESH: Neoplasm Staging ,Middle Aged ,Oncology ,030220 oncology & carcinogenesis ,Female ,Adult ,Aged ,Antibodies, Monoclonal, Humanized ,Double-Blind Method ,Humans ,Neoplasm Staging ,medicine.medical_specialty ,MESH: Melanoma ,Population ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Placebo ,Antibodies ,03 medical and health sciences ,All institutes and research themes of the Radboud University Medical Center ,Internal medicine ,medicine ,Adjuvant therapy ,education ,Cancer staging ,MESH: Humans ,business.industry ,MESH: Skin Neoplasms ,MESH: Adult ,MESH: Neoplasm Metastasis ,MESH: Male ,Clinical trial ,MESH: Antibodies, Monoclonal, Humanized ,business ,MESH: Female - Abstract
Background: The European Organisation for Research and Treatment of Cancer (EORTC) 1325/KEYNOTE-054 trial assessed pembrolizumab versus placebo in patients with resected high-risk stage III melanoma. At 15-month median follow-up, pembrolizumab improved recurrence-free survival (hazard ratio [HR] 0·57 [98·4% CI 0·43–0·74], p1 mm), IIIB, or IIIC (without in-transit metastasis), and with an Eastern Cooperative Oncology Group performance status of 0 or 1 were eligible. Patients were randomly assigned (1:1) via a central interactive voice response system to receive intravenous pembrolizumab 200 mg or placebo every 3 weeks for up to 18 doses or until disease recurrence or unacceptable toxicity. Randomisation was stratified according to disease stage and region, using a minimisation technique, and clinical investigators, patients, and those collecting or analysing the data were masked to treatment assignment. The two coprimary endpoints were recurrence-free survival in the intention-to-treat (ITT) population and in patients with PD-L1-positive tumours. The secondary endpoint reported here was distant metastasis-free survival in the ITT and PD-L1-positive populations. This study is registered with ClinicalTrials.gov, NCT02362594, and EudraCT, 2014-004944-37. Findings: Between Aug 26, 2015, and Nov 14, 2016, 1019 patients were assigned to receive either pembrolizumab (n=514) or placebo (n=505). At an overall median follow-up of 42·3 months (IQR 40·5–45·9), 3·5-year distant metastasis-free survival was higher in the pembrolizumab group than in the placebo group in the ITT population (65·3% [95% CI 60·9–69·5] in the pembrolizumab group vs 49·4% [44·8–53·8] in the placebo group; HR 0·60 [95% CI 0·49–0·73]; p
- Published
- 2021
- Full Text
- View/download PDF
225. Romidepsin-induced sterile folliculitis in a patient with Sézary syndrome
- Author
-
Pablo L. Ortiz-Romero, Daniel Falkenhain-López, Alba Sánchez-Velázquez, Cristina Vico-Alonso, José Luis Rodríguez-Peralto, and Concepción Postigo-Llorente
- Subjects
Folliculitis ,medicine.medical_specialty ,Skin Neoplasms ,business.industry ,Dermatology ,medicine.disease ,Romidepsin ,Depsipeptides ,Medicine ,Humans ,Sezary Syndrome ,business ,medicine.drug - Published
- 2021
226. UVA-Degradable Collagenase Nanocapsules as a Potential Treatment for Fibrotic Diseases
- Author
-
Carolina Meroño, Alicia Usategui, María Vallet-Regí, Victor Moreno, Alejandro Baeza, Pablo L. Ortiz-Romero, and José L. Pablos
- Subjects
collagen ,lcsh:RS1-441 ,Pharmaceutical Science ,02 engineering and technology ,010402 general chemistry ,collagenase nanocapsules ,01 natural sciences ,Nanocapsules ,Article ,lcsh:Pharmacy and materia medica ,medicine ,Uva irradiation ,photolinker ,chemistry.chemical_classification ,Materiales ,Chemistry ,Ultraviolet a ,021001 nanoscience & nanotechnology ,0104 chemical sciences ,3. Good health ,Enzyme ,UVA ,Collagenase ,Biophysics ,0210 nano-technology ,medicine.drug ,fibrotic diseases - Abstract
Peyronie and Dupuytren are pathologies characterized by the appearance of localized fibrotic lesions in an organ. These disorders originate from an excessive production of collagen in the tissue provoking dysfunction and functional limitations to the patients. Local administration of collagenase is the most used treatment for these fibrotic-type diseases, but a high lability of the enzyme limits its therapeutic efficacy. Herein, we present a novel methodology for the preparation of collagenase nanocapsules without affecting its enzymatic activity and capable of releasing the enzyme in response to an ultraviolet A (UVA) light stimulus. Polymeric coating around collagenase was formed by free-radical polymerization of acrylamide-type monomers. Their degradation capacity under UVA irradiation was provided by incorporating a novel photocleavable acrylamide-type crosslinker within the polymeric framework. This property allowed collagenase release to be triggered in a controlled manner by employing an easily focused stimulus. Additionally, UVA irradiation presents considerable benefits by itself due to its capacity to induce collagenase production in situ. An expected synergistic effect of collagenase nanocapsules in conjunction with UVA effect may present a promising treatment for these fibrotic diseases.
- Published
- 2021
- Full Text
- View/download PDF
227. Mycosis Fungoides and Sézary Syndrome: An Integrative Review of the Pathophysiology, Molecular Drivers, and Targeted Therapy
- Author
-
Nuria García-Díaz, José P. Vaqué, Pablo L. Ortiz-Romero, Miguel A. Piris, and Universidad de Cantabria
- Subjects
0301 basic medicine ,Cancer Research ,diagnosis ,medicine.medical_treatment ,Translational research ,Review ,stat ,Targeted therapy ,03 medical and health sciences ,Mycosis Fungoides ,0302 clinical medicine ,CTCL ,Diagnosis ,medicine ,PLCG1 ,RC254-282 ,Mycosis fungoides ,therapy ,Molecular Drivers ,business.industry ,mycosis fungoides ,T-cell receptor ,molecular drivers ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Sézary Syndrome ,medicine.disease ,030104 developmental biology ,Oncology ,030220 oncology & carcinogenesis ,Sézary syndrome ,Cancer research ,STAT protein ,Therapy ,Janus kinase ,business - Abstract
Simple Summary In the last few years, the field of cutaneous T-cell lymphomas has experienced major advances. In the context of an active translational and clinical research field, next-generation sequencing data have boosted our understanding of the main molecular mechanisms that govern the biology of these entities, thus enabling the development of novel tools for diagnosis and specific therapy. Here, we focus on mycosis fungoides and Sézary syndrome; we review essential aspects of their pathophysiology, provide a rational mechanistic interpretation of the genomic data, and discuss the current and upcoming therapies, including the potential crosstalk between genomic alterations and the microenvironment, offering opportunities for targeted therapies. Abstract Primary cutaneous T-cell lymphomas (CTCLs) constitute a heterogeneous group of diseases that affect the skin. Mycosis fungoides (MF) and Sézary syndrome (SS) account for the majority of these lesions and have recently been the focus of extensive translational research. This review describes and discusses the main pathobiological manifestations of MF/SS, the molecular and clinical features currently used for diagnosis and staging, and the different therapies already approved or under development. Furthermore, we highlight and discuss the main findings illuminating key molecular mechanisms that can act as drivers for the development and progression of MF/SS. These seem to make up an orchestrated constellation of genomic and environmental alterations generated around deregulated T-cell receptor (TCR)/phospholipase C, gamma 1, (PLCG1) and Janus kinase/ signal transducer and activator of transcription (JAK/STAT) activities that do indeed provide us with novel opportunities for diagnosis and therapy.
- Published
- 2021
228. PLCγ1/PKCθ and its downstream effectors in cutaneous T-cell lymphoma development and progression
- Author
-
Anna Esteve-Codina, M. Rodriguez, Carmen González-Vela, Nuria García-Díaz, José P. Vaqué, Berta Casar, Fulgencio Ruso-Julve, Marta Gut, Pablo L. Ortiz-Romero, Ruth Alonso-Alonso, Miguel A. Piris, José Luis Rodríguez-Peralto, Alejandro A. Gru, Ivo Gut, and Ignacio Varela
- Subjects
Cancer Research ,Oncology ,Downstream (manufacturing) ,Effector ,Cutaneous T-cell lymphoma ,Cancer research ,medicine ,Biology ,medicine.disease - Published
- 2021
- Full Text
- View/download PDF
229. SPONTANEOUS BILATERAL NON-RESOLVING PNEUMOTHORAX AS A COMPLICATION OF SEVERE SARS-COV-2 INFECTION
- Author
-
Jose Rodriguez Velez, Kyomara Hernandez-Moya, Marlene Farinacci Vilaro, Juan Garcia-Puebla, Kimberly Padilla Rodriguez, Jose Adorno-Fontanez, Pablo Rodriguez-Ortiz, Jonathan Martinez, Ricardo Fernández, and Arnaldo Nieves-Ortiz
- Subjects
Pulmonary and Respiratory Medicine ,2019-20 coronavirus outbreak ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,Critical Care and Intensive Care Medicine ,medicine.disease ,Virology ,Disorders of the Pleura ,Pneumothorax ,medicine ,Cardiology and Cardiovascular Medicine ,Complication ,business - Published
- 2021
230. Lacutamab in patients (pts) with advanced mycosis fungoides (MF) according to KIR3DL2 expression: early results from the TELLOMAK phase 2 trial
- Author
-
Pierluigi Porcu, Maxime Battistella, Andrea Cambalia, Federico Rotolo, Youn H. Kim, Marie Beylot-Barry, Pier Luigi Zinzani, Olivier Dereure, Hélène Moins-Teisserenc, Eric N. Jacobsen, Alejandro A. Gru, Christine Paiva, Pablo L. Ortiz-Romero, Hatem A. Azim, Agnès Boyer-Chammard, Stéphane Dalle, Laurent Mortier, and Martine Bagot
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Mycosis fungoides ,Early results ,KIR3DL2 ,business.industry ,Internal medicine ,Medicine ,In patient ,business ,medicine.disease - Published
- 2021
- Full Text
- View/download PDF
231. International Cutaneous Lymphomas Pandemic Section (ICLYPS) analysis of CTCL outcomes during COVID-19
- Author
-
Larisa J Geskin, Tiffany Garcia-Saleem, Oleg E Akilov, Paula Enz, Emmanuella Guenova, Pablo L Ortiz-Romero, Evangelia Papadavid, Pietro Quaglino, Sima Rozati, Connor Stonesifer, Austin Burns, Alexandra Khaleel, and Julia J Scarisbrick
- Subjects
Cancer Research ,Pediatrics ,medicine.medical_specialty ,Mycosis fungoides ,business.industry ,patient outcomes research ,Cancer ,COVID-19 ,medicine.disease ,Cutaneous lymphoma ,Patient safety ,Oncology ,Maintenance therapy ,Pandemic ,Cohort ,medicine ,Oral Presentations: Epidemiology ,Stage (cooking) ,business ,Cutaneous T cell lymphoma (CTCL) - Abstract
At the onset of the COVID-19 pandemic, the United States Cutaneous Lymphoma Consortium (USCLC) and the European Organisation for Research and Treatment of Cancer Cutaneous Lymphoma Task Force (EORTC-CLTF) developed emergency guidelines for the management of patients with cutaneous lymphomas (CLs) during the pandemic. These emergency protocols were intended to ensure patient safety and called for dose modifications, treatment delays and treatment interruptions as necessary to minimize exposure risks to COVID-19. Because there are no established maintenance protocols for CLs, the impact of such delays or interruptions on disease outcomes was not known. The ISCL created an International Cutaneous Lymphomas Pandemic Section (ICLYPS) to collect data from the institutions around the world to assess the impact of these changes on patients' outcomes and to determine if these measures were effective in preventing infection. We summarize the outcomes from a preliminary cohort of patients from Brazil, Greece, Italy, Spain, Switzerland, the UK and the US. Actively managed patients with an established diagnosis of CL from March to October 2020 were included according to the Institutional Protection of Human Subjects guidelines at the respective centers. We included 149 patients in this retrospective review. The average age was 61.88 years (range: 22–95). 2 patients (1.3%) had diagnoses of CD30+ lymphoproliferative disorders (LyP and pcALCL), 112 (75.2%) had mycosis fungoides (MF), and 35 (23.5%) had Sezary syndrome (SS). 77 patients (68.7%) had stages IA–IIA MF, 23 (20.5%) had Stage IIB MF, 6 (5.4%) had stage III MF, and 41 (27.5%) had Stage IV disease, of which 6 had Stage IV MF (5.4%) and 35 had SS (23.5%). Treatment was delayed for more than half (53.0%) of the patients for a mean of 3.2 months (range: 10 days to 10 months). Treatment delay was associated with a significant risk of disease relapse or progression across all stages (65.8% vs 32.9%, p
- Published
- 2021
232. Response to brentuximab vedotin versus physician's choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis
- Author
-
Meredith Little, Lisa Brown, José Antonio Sanches, Pietro Quaglino, J. Scarisbrick, Oliver Bechter, Kerry Taylor, David E. Fisher, Matthew Onsum, M. Corinna Palanca-Wessels, Veronica Bunn, Pascal Wolter, Steven M. Horwitz, Jan Walewski, Judith Trotman, Madeleine Duvic, Rudolf Stadler, Lauren C. Pinter-Brown, Herbert Eradat, Reinhard Dummer, Pier Luigi Zinzani, Marise McNeeley, Sean Whittaker, Alejandro A. Gru, Pablo L. Ortiz-Romero, Julie Lisano, H. Miles Prince, Michael Weichenthal, Youn H. Kim, William L. Trepicchio, Oleg E. Akilov, Kim Y.H., Prince H.M., Whittaker S., Horwitz S.M., Duvic M., Bechter O., Sanches J.A., Stadler R., Scarisbrick J., Quaglino P., Zinzani P.L., Wolter P., Eradat H., Pinter-Brown L.C., Ortiz-Romero P.L., Akilov O.E., Trotman J., Taylor K., Weichenthal M., Walewski J., Fisher D., McNeeley M., Gru A.A., Brown L., Palanca-Wessels M.C., Lisano J., Onsum M., Bunn V., Little M., Trepicchio W.L., and Dummer R.
- Subjects
0301 basic medicine ,Oncology ,Male ,Cancer Research ,Lymphoma ,Choice Behavior ,0302 clinical medicine ,Antineoplastic Agents, Immunological ,immune system diseases ,Retrospective Studie ,hemic and lymphatic diseases ,Objective response ,80 and over ,Brentuximab vedotin ,Cancer ,Aged, 80 and over ,Brentuximab Vedotin ,Mycosis Fungoide ,integumentary system ,medicine.diagnostic_test ,Antibody-drug conjugate ,CD30 ,Cutaneous T-cell lymphoma ,Efficacy ,Large-cell transformation ,Mycosis fungoides ,Progression-free survival ,Safety ,Hematology ,Middle Aged ,Prognosis ,Survival Rate ,Immunological ,International Agencie ,030220 oncology & carcinogenesis ,Public Health and Health Services ,Female ,medicine.drug ,Human ,Adult ,medicine.medical_specialty ,Prognosi ,Oncology and Carcinogenesis ,Ki-1 Antigen ,Antineoplastic Agents ,Follow-Up Studie ,Decision Support Techniques ,03 medical and health sciences ,Young Adult ,Rare Diseases ,Clinical Research ,Internal medicine ,Physicians ,Biopsy ,medicine ,Humans ,Oncology & Carcinogenesis ,Retrospective Studies ,Aged ,business.industry ,International Agencies ,medicine.disease ,Clinical trial ,030104 developmental biology ,Orphan Drug ,Physician ,business ,Follow-Up Studies - Abstract
INTRODUCTION: Mycosis fungoides (MF), the most common type of cutaneous T-cell lymphoma, can lead to disfiguring lesions, debilitating pruritus and frequent skin infections. This study assessed response to brentuximab vedotin in patients with MF in the phase III ALCANZA study. METHODS: Baseline CD30 levels and large-cell transformation (LCT) status were centrally reviewed in patients with previously-treated CD30-positive MF using ≥2 skin biopsies obtained at screening; eligible patients required ≥1 biopsy with ≥10% CD30 expression. Patients were categorised as CD30min
- Published
- 2021
233. The effect of the lockdown executive order during the COVID-19 pandemic in recent trauma admissions in Puerto Rico
- Author
-
Pablo Rodríguez-Ortiz, Kerwin X Cruz-De La Rosa, Lourdes Guerrios-Rivera, Mariely Nieves-Plaza, Antonio Arrieta-Alicea, Pedro E. Ruiz-Medina, and Ediel O. Ramos-Meléndez
- Subjects
medicine.medical_specialty ,Psychological intervention ,Rate ratio ,Trauma ,03 medical and health sciences ,symbols.namesake ,0302 clinical medicine ,Statistical significance ,Lockdown ,Epidemiology ,Medicine ,030212 general & internal medicine ,Social isolation ,Fisher's exact test ,Pandemic ,business.industry ,lcsh:Public aspects of medicine ,Mortality rate ,lcsh:Medical emergencies. Critical care. Intensive care. First aid ,COVID-19 ,lcsh:RA1-1270 ,030208 emergency & critical care medicine ,lcsh:RC86-88.9 ,Original Contribution ,General Medicine ,symbols ,Biostatistics ,medicine.symptom ,Injury patterns ,business ,Demography - Abstract
Background The COVID-19 pandemic led to world-wide restrictions on social activities to curb the spread of this disease. Very little is known about the impact of these restrictions on trauma centers. Our objective was to determine the effect of the pandemic-associated lockdown on trauma admissions, patient’s demographics, mechanisms of injury, injury severity, and outcomes in the Puerto Rico Trauma Hospital. Methods An IRB-approved quasi-experimental study was performed to assess the impact of the restrictions by comparing trauma admissions during the lockdown (March 15, 2020 – June 15, 2020) with a control period (same period in 2017–2019). Comparisons were done using the Pearson’s chi-square test, Fisher exact test, or Mann-Whitney U test, as appropriate. A negative binomial model was fitted to estimate the incidence rate ratio for overall admissions among pre-lockdown and during-lockdown periods. Statistical significance was set at p Results A total of 308 subjects were admitted during the quarter of study for 2017; 323, for 2018; 347, for 2019; and 150, for 2020. The median (interquartile range) age of patients rose significantly from 40 (33) years to 49 (30) years (p p = 0.026). Moreover, the proportion of severe cases decreased, as measured by an injury severity score (ISS) > 15 (37.3% vs. 26.8%; p = 0.014); while there were no differences in the median hospital length of stay and the mortality rate between the comparison groups. Finally, the decrease in overall admissions registered during the lockdown accounts for a 59% (IRR 0.41; 95% CI 0.31–0.54) change compared to the pre-lockdown period, when controlling for sex, age, mechanism of injury, and ISS. Conclusions Following periods of social isolation and curfews, trauma centers can expect drastic reductions in their overall patient volume with associated changes in trauma patterns. Our findings will help inform new interventions and improve healthcare preparedness for future or similar circumstances.
- Published
- 2021
- Full Text
- View/download PDF
234. A study of the heterochronic sense/antisense RNA representation in florets of sexual and apomictic Paspalum notatum
- Author
-
Lorena Adelina Siena, Juan Pablo A. Ortiz, Maricel Podio, Silvina Claudia Pessino, and Carolina Colono
- Subjects
lcsh:QH426-470 ,lcsh:Biotechnology ,Apospory ,Biology ,Plant reproduction ,Transcriptome ,Anthesis ,Meiosis ,Gene Expression Regulation, Plant ,lcsh:TP248.13-248.65 ,Apomixis ,Sense (molecular biology) ,Genetics ,RNA, Antisense ,Paspalum ,Plant Proteins ,Parthenogenesis ,Antisense RNA ,lcsh:Genetics ,Seeds ,Molecular breeding ,Research Article ,Biotechnology - Abstract
Background Apomixis, an asexual mode of plant reproduction, is a genetically heritable trait evolutionarily related to sexuality, which enables the fixation of heterozygous genetic combinations through the development of maternal seeds. Recently, reference floral transcriptomes were generated from sexual and apomictic biotypes of Paspalum notatum, one of the most well-known plant models for the study of apomixis. However, the transcriptome dynamics, the occurrence of apomixis vs. sexual expression heterochronicity across consecutive developmental steps and the orientation of transcription (sense/antisense) remain unexplored. Results We produced 24 Illumina TruSeq®/ Hiseq 1500 sense/antisense floral transcriptome libraries covering four developmental stages (premeiosis, meiosis, postmeiosis, and anthesis) in biological triplicates, from an obligate apomictic and a full sexual genotype. De novo assemblies with Trinity yielded 103,699 and 100,114 transcripts for the apomictic and sexual samples respectively. A global comparative analysis involving reads from all developmental stages revealed 19,352 differentially expressed sense transcripts, of which 13,205 (68%) and 6147 (32%) were up- and down-regulated in apomictic samples with respect to the sexual ones. Interestingly, 100 differentially expressed antisense transcripts were detected, 55 (55%) of them up- and 45 (45%) down-regulated in apomictic libraries. A stage-by-stage comparative analysis showed a higher number of differentially expressed candidates due to heterochronicity discrimination: the highest number of differential sense transcripts was detected at premeiosis (23,651), followed by meiosis (22,830), postmeiosis (19,100), and anthesis (17,962), while the highest number of differential antisense transcripts were detected at anthesis (495), followed by postmeiosis (164), meiosis (120) and premeiosis (115). Members of the AP2, ARF, MYB and WRKY transcription factor families, as well as the auxin, jasmonate and cytokinin plant hormone families appeared broadly deregulated. Moreover, the chronological expression profile of several well-characterized apomixis controllers was examined in detail. Conclusions This work provides a quantitative sense/antisense gene expression catalogue covering several subsequent reproductive developmental stages from premeiosis to anthesis for apomictic and sexual P. notatum, with potential to reveal heterochronic expression between reproductive types and discover sense/antisense mediated regulation. We detected a contrasting transcriptional and hormonal control in apomixis and sexuality as well as specific sense/antisense modulation occurring at the onset of parthenogenesis.
- Published
- 2021
- Full Text
- View/download PDF
235. Dermoscopy and reflectance confocal microscopy features of acquired lymphangiectasias following surgery and radiotherapy of breast cancer
- Author
-
Mario Puerta-Peña, Maria Penalba‐Torres, Virginia Velasco-Tamariz, José Luis Rodríguez-Peralto, and Pablo L. Ortiz-Romero
- Subjects
Reflectance confocal microscopy ,medicine.medical_specialty ,Microscopy, Confocal ,Skin Neoplasms ,business.industry ,medicine.medical_treatment ,Breast Neoplasms ,Dermoscopy ,Dermatology ,medicine.disease ,Radiation therapy ,Breast cancer ,medicine ,Humans ,Female ,Radiology ,business - Published
- 2021
236. Elderly Admission Trends at the Puerto Rico Trauma Hospital: A Time-Series Analysis
- Author
-
Adrianna I. Rivera-Delgado, Ediel O. Ramos-Meléndez, Laura V. Ramírez-Martínez, Javier R. Ruiz-Rodríguez, Pedro E. Ruiz-Medina, Lourdes Guerrios-Rivera, and Pablo Rodríguez-Ortiz
- Subjects
Hospitalization ,Injury Severity Score ,Trauma Centers ,Puerto Rico ,Humans ,Wounds and Injuries ,Surgery ,Hospital Mortality ,Hospitals ,Aged ,Retrospective Studies - Abstract
The aging process places the elderly, a worldwide increasing age group, at an increased risk for trauma. This study aims to explore changes over time in admission rates, sociodemographical, clinical, and injury-related data in elderly patients (aged ≥65 y) admitted to the Puerto Rico Trauma Hospital (PRTH) during 2000-2019.A time-series analysis was conducted. Admission rates were analyzed by fitting an exponential growth curve model. Trends were assessed using the Cochrane-Armitage and Cuzick tests for categorical and continuous data, respectively.Elderly admission rates to the PRTH have shown growth over the past 2 decades, from 6.2 cases per 100 overall admissions in 2000 to 18.2 in 2019. This trend is projected to continue with estimated 24.8 (95% CI: 21.7-27.8) cases per 100 overall admissions in 2023. Trends for mechanisms of injury such as motor vehicle accidents and pedestrians showed a significant decrease, whereas falls presented a clear positive trend, showing an increase from 25.6% in 2000-2004 to 46.2% in 2015-2019. Both Injury Severity Score ≥25 and Glasgow Coma Scale ≤8 declined significantly through time. Finally, in-hospital mortality presented a decreasing trend from 31.7% in 2000-2004 to 21.5% in 2015-2019.Our analysis demonstrates an increase over time in elderly admissions, especially fall-related trauma. Also, it projects this upward trend will continue. This imposes new challenges for PRTH and other healthcare services and is a gateway for the implementation of adapted clinical management.
- Published
- 2021
237. The Fossil Record of Camelids (Mammalia, Cetartiodactyla) in Tucumán Province, Northwestern Argentina
- Author
-
Vanessa Torres-Carro, Daniel A. García-López, and Pablo E. Ortiz
- Subjects
010506 paleontology ,biology ,Pleistocene ,Paleontology ,Postcrania ,Context (language use) ,010502 geochemistry & geophysics ,biology.organism_classification ,01 natural sciences ,Archaeology ,Geography ,Synonym (taxonomy) ,Palaeolama ,Vicugna ,Quaternary ,Ecology, Evolution, Behavior and Systematics ,Holocene ,0105 earth and related environmental sciences - Abstract
The presence of fossil camelids in Tucuman, northwestern Argentina, has been recognized for many years but its relevance has not been fully evaluated so far. Here, we review previous mentions of fossil camelids for this province, present new material, and compare it with fossil and extant specimens of South American camelids, clarifying its taxonomic context and discussing its paleobiogeographic significance. For Tucuman we recognize Vicugna vicugna (Tafi del Valle Formation, late Pleistocene–early Holocene) and Palaeolama sp. (Tucuman Formation, late Pleistocene), mainly based on size and dental features. The current distribution of V. vicugna is restricted to the Central Andes, in the Puna and High Andean environments over 3200 m altitude; there is no mention, neither current nor historical, for Tucuman. Its presence at around 2200 m in the Tafi valley during the Quaternary indicates cooler and drier conditions than those currently established. The observations made in the context of this contribution allow us to establish that the species V. provicugna is a synonym of V. vicugna. In turn, we consider that the validity of the species Palaeolama hoffstetteri, only based on postcranial remains, should be properly evaluated in the future.
- Published
- 2021
- Full Text
- View/download PDF
238. Paraneoplastic pemphigus associated with Castleman's disease and thyroid carcinoma with anti-BP180, BP230 and antidesmocollin autoantibodies
- Author
-
Álvaro Gimeno-Díaz de Atauri, Sara Palencia-Pérez, Alba Calleja-Algarra, Cristina de Manuel-Gómez, Virginia Velasco-Tamariz, Norito Ishii, Takashi Hashimoto, Laura Caldevilla-Asenjo, Pablo Luis Ortiz Romero, José Luis Rodríguez Peralto, and Carlos Zarco Olivo
- Subjects
Pathology ,medicine.medical_specialty ,business.industry ,Paraneoplastic Syndromes ,Castleman Disease ,Autoantibody ,Dermatology ,Disease ,medicine.disease ,Thyroid carcinoma ,Paraneoplastic pemphigus ,Medicine ,Humans ,Thyroid Neoplasms ,business ,Pemphigus ,Autoantibodies - Published
- 2021
239. Spectrum of Clinicopathologic Findings in COVID-19-induced Skin Lesions: Demonstration of Direct Viral Infection of the Endothelial Cells
- Author
-
Maria C. Garrido Ruiz, Ángel Santos-Briz, Alba Sánchez, Marina Alonso-Riaño, Juan Burgos, Mario Medina-Miguelañez, Laura Puebla, Concepción Román-Curto, Mónica Roncero-Riesco, Rosa Garcia, Pablo L. Ortiz, and Jose-Luis Rodriguez-Peralto
- Subjects
Adult ,Male ,Pathology ,medicine.medical_specialty ,Adolescent ,Context (language use) ,Disease ,medicine.disease_cause ,Severity of Illness Index ,Skin Diseases ,Virus ,Pathology and Forensic Medicine ,030207 dermatology & venereal diseases ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,COVID-19 Testing ,Severity of illness ,medicine ,Humans ,Respiratory system ,Young adult ,Coronavirus ,Aged ,Retrospective Studies ,Aged, 80 and over ,business.industry ,COVID-19 ,Endothelial Cells ,Middle Aged ,Purpura ,Microscopy, Electron ,030220 oncology & carcinogenesis ,Surgery ,Female ,Anatomy ,medicine.symptom ,business - Abstract
The novel coronavirus disease (COVID-19) is a rapidly spreading pandemic, secondary to severe acute respiratory syndrome coronavirus 2. The severity and the little knowledge that we have of the disease have made us focus mostly on the respiratory symptoms. As we bend the curve, other findings reported in association with COVID-19 become of importance for specialists to recognize. We describe the spectrum of clinicopathologic lesions in the skin that can be the only symptom or the first manifestation of COVID-19 and demonstrate the origin of the virus. We collected 25 patients with skin lesions in this context. We recognized 5 types of cutaneous manifestations including acute acroischemic or chilblain-like lesions (11), purpura palpable (2), exanthemas (9), urticarial eruptions (1), and other lesions (2) that might appear with more unspecific pictures. Chilblain-like lesions were the most common form of presentation, which tend to appear as self-healing, erythematous-necrotic plaques mostly on the feet, in young patients with no systemic symptoms associated. Importantly, we visualized viral particles with electron microscopy in 5 of 13 cases analyzed. In this study, we seek to draw a picture of the spectrum of clinicopathologic lesions that may appear in the skin in the context of COVID-19. Although apparently skin lesions are not correlated with disease severity, it may help in some cases to recognize and control the spread of the infection sooner.
- Published
- 2021
240. Patients with Primary Cutaneous Lymphoma are at risk for severe COVID-19. Data from the Spanish Primary Cutaneous Lymphoma Registry
- Author
-
Ignacio García-Doval, L Haya, V Morillas, Miguel Ángel Descalzo, Elvira Acebo, Jorge Arroyo-Andrés, L. Calzado, J D Domínguez, Hae Jin Suh-Oh, Alba Sánchez-Velázquez, Cristina Muniesa, P Sánchez-Caminero, A Bauer-Alonso, A Pérez-Ferriols, Teresa Estrach, R. Izu, L Prieto-Torres, Andrea Combalia, M. Morillo, J Sarriugarte, Pablo L. Ortiz-Romero, D Vega-Díez, Rafael Botella-Estrada, E Silva-Díaz, Yeray Peñate, A Pérez, A Mateu-Puchades, P Garcia-Muret, R. Fernández de Misa, M. Blanes, M Navedo, and C Román-Curto
- Subjects
medicine.medical_specialty ,Skin Neoplasms ,Coronavirus disease 2019 (COVID-19) ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,Dermatology ,SARS‐CoV‐2 ,Cutaneous lymphoma ,Mycosis Fungoides ,COVID‐19 ,medicine ,Humans ,Registries ,Letters to the Editor ,Letter to the Editor ,Mycosis fungoides ,SARS-CoV-2 ,business.industry ,Primary cutaneous lymphoma ,COVID-19 ,medicine.disease ,Lymphoma, T-Cell, Cutaneous ,Lymphoma ,Infectious Diseases ,Increased risk ,Sézary syndrome ,oncology ,Cutaneous Lymphoma ,business - Abstract
While some papers report an increased risk of COVID-19 and worse outcomes1 in oncological patients, others have found no differences2 . We are not aware of studies assessing risk for COVID-19 and clinical outcomes of patients with Primary Cutaneous Lymphomas (PCL).
- Published
- 2021
241. Health-related quality of life effect of mogamulizumab by patient blood involvement
- Author
-
Pablo L. Ortiz-Romero, Pier Luigi Zinzani, Margarida Lima, Auris Huen, Zinzani P.L., Ortiz-Romero P., Lima M., and Huen A.O.
- Subjects
Health related quality of life ,mycosis fungoide ,Cancer Research ,medicine.medical_specialty ,Mycosis fungoides ,business.industry ,mogamulizumab ,MAVORIC ,medicine.disease ,Quality of life (healthcare) ,CTCL ,Oncology ,quality of life ,Sézary syndrome ,Mogamulizumab ,Medicine ,business ,Intensive care medicine ,medicine.drug - Abstract
NA
- Published
- 2021
242. Validation of a Histologic Scoring Index for C3 Glomerulopathy
- Author
-
Macarena Centeno, Sofía Pérez Gutiérrez, Eduardo Vázquez Martul, Adriana García-Herrera, Dolores López Álvarez, Natalia Allende, M. Luisa Pérez-Ebri, Gema Fernández-Juárez, Helena Marco, Alejandra Gabaldón Domínguez, Alberto Lorenzo, Alexandra Navarro, Gloria Fraga, Francisco Caravaca, Xoana Barros, Cesáreo Corbacho Cuevas, Ana Ávila, Carmen Mon, Lucia González, Hernando Trujillo, Eva Rodríguez, Francisco Díaz Crespo, Consuelo Calvo, Marina Alonso, Angel Sevillano, Ana Saiz, Cristina Meléndez Muñoz, Ángel Panizo Santos, Vanessa Pérez Gómez, Sonia Cruz, Ana Pérez de José, Juliana Draibe, Esther Roselló Sastre, Montserrat Díaz-Encarnación, Rafael Camacho Galán, José Antonio Cortés, Luis Bravo, Belén Ferri Ñíguez, Victoria Oviedo, Fernando Caravaca-Fontán, Juan Mosquera Reboredo, Iara Da Silva, Maria Dolores Sanchez de la Nieta, Javier Lumbreras, Javier Gimeno, Carmen Guerrero Márquez, Rosa Rodríguez, Luis F. Quintana, Carles Saus, Maria Soledad Garcia-Cuerva Calvar, Rocío Cabrera-Pérez, Amir Shabaka, Virginia Cabello, Elena Goicoechea de Jorge, Enrique Morales, F. González, Ana Huerta, Teresa Cavero, Marta Garrido, Inmaculada López, Natalia Ramos, Francisco de la Cerda, Teresa Olea, Rosa Miquel, Nuria Rodríguez-Mendiola, Maria Luisa Illescas, Pablo Cannata Ortiz, Loreto Fernández, Manuel Praga, Eduardo Salido Ruiz, Eduardo Gutiérrez, Maria Eugenia García Fernández, Montserrat Gomà Gallego, Gema Ariceta, Alejando Pascual Martin, Laura Yébenes Gregorio, Marta Melgosa, Yolanda Arce, Instituto de Salud Carlos III, European Commission, Red Española de Investigación Renal, Comunidad de Madrid, Ministerio de Ciencia, Innovación y Universidades (España), Caravaca-Fontán, Fernando, Trujillo, Hernando, Alonso, Marina, Díaz-Encarnación, Montserrat M., Cabello, Virginia, Ariceta, Gema, Quintana, Luis F., Barros, Xoana, Ramos, Natalia, Rodríguez-Mendiola, Nuria, Fernández-Juárez, Gema, de la Cerda, Francisco, Pérez de José, Ana, Pérez Gómez, Vanessa, Lumbreras, Javier, Sánchez de la Nieta, María Dolores, Olea, Teresa, Melgosa, Marta, Huerta, Ana, de Lorenzo, Alberto, Draibe, Juliana, González, Fayna, Shabaka, Amir, Goicoechea de Jorge, Elena, Praga, Manuel, Caravaca-Fontán, Fernando [0000-0002-5830-9663], Trujillo, Hernando [0000-0002-3520-1422], Alonso, Marina [0000-0003-1293-1075], Díaz-Encarnación, Montserrat M. [0000-0001-5172-3370], Cabello, Virginia [0000-0002-0877-5498], Ariceta, Gema [0000-0003-1763-1098], Quintana, Luis F. [0000-0001-7582-8476], Barros, Xoana [0000-0001-9690-9769], Ramos, Natalia [0000-0001-9832-326X], Rodríguez-Mendiola, Nuria [0000-0001-6994-7161], Fernández-Juárez, Gema [0000-0001-6641-7763], de la Cerda, Francisco [0000-0002-9983-0359], Pérez de José, Ana [0000-0002-6952-1459], Pérez Gómez, Vanessa [0000-0003-4558-5236], Lumbreras, Javier [0000-0003-1855-0724], Sánchez de la Nieta, María Dolores [0000-0001-8574-0013], Olea, Teresa [0000-0003-2370-1048], Melgosa, Marta [0000-0001-6236-414X], Huerta, Ana [0000-0003-3342-7628], de Lorenzo, Alberto [0000-0001-8847-083X], Draibe, Juliana [0000-0002-2819-8560], González, Fayna [0000-0002-2313-2511], Shabaka, Amir [0000-0001-7039-4701], Goicoechea de Jorge, Elena [0000-0002-4978-2483], and Praga, Manuel [0000-0001-9270-1071]
- Subjects
Nephrology ,Male ,Total activity Score ,Intraclass correlation ,Dense-deposit disease (DDD) ,total chronicity score ,030232 urology & nephrology ,Kidney biopsy ,disease prognosis ,Kidney ,C3 glomerulonephritis (C3GN) ,Cohort Studies ,0302 clinical medicine ,Glomerulonephritis ,Intraclass correlations ,Medicine ,030212 general & internal medicine ,Renal Insufficiency ,Child ,intraclass correlations ,Proteinuria ,Confounding ,dense-deposit disease (DDD) ,Complement C3 ,Disease prognosis ,Middle Aged ,Prognosis ,kidney survival ,Kidney survival ,Kidney Tubules ,Disease Progression ,Female ,kidney failure ,total activity Score ,medicine.symptom ,Immunosuppressive Agents ,Glomerular Filtration Rate ,Adult ,medicine.medical_specialty ,Adolescent ,Glomerulonephritis, Membranoproliferative ,Renal function ,Kidney failure ,histologic index ,prognostic tool ,Prognostic tool ,03 medical and health sciences ,Young Adult ,Glomerulopathy ,C3 glomerulopathy (C3G) ,Internal medicine ,kidney biopsy ,Total chronicity score ,Humans ,Proportional Hazards Models ,Retrospective Studies ,business.industry ,Proportional hazards model ,Reproducibility of Results ,Retrospective cohort study ,medicine.disease ,Fibrosis ,Histologic index ,Atrophy ,business - Abstract
12 p.-4 fig.-4 tab., Rationale & objective: A previous study that evaluated associations of kidney biopsy findings with disease progression in patients with C3 glomerulopathy (C3G) proposed a prognostic histologic index (C3G-HI) that has not yet been validated. Our objective was to validate the performance of the C3G-HI in a new patient population., Study design: Multicenter, retrospective cohort study., Setting & participants: 111 patients fulfilling diagnostic criteria of C3G between January 1995 and December 2019, from 33 nephrology departments belonging to the Spanish Group for the Study of Glomerular Diseases (GLOSEN)., Predictors: Demographic, clinical parameters, C3G-HI total activity score, and the C3G-HI total chronicity score., Outcome: Time to kidney failure., Analytical approach: Intraclass correlation coefficients and κ statistic were used to summarize inter-rater reproducibility for assessment of histopathology in kidney biopsies. The nonlinear relationships of risk of kidney failure with the total activity score and total chronicity score were modeled using Cox proportional hazards analysis that incorporated cubic splines., Results: The study group included 93 patients with C3 glomerulonephritis and 18 with dense-deposit disease. Participants had an overall meanage of 35±22 (SD) years. Forty-eight patients (43%) developed kidney failure after a mean follow-up of 65±27 months. The overall inter-rater reproducibility was very good for the total activity score (intraclass correlation coefficient [ICC]=0.63) and excellent for total chronicity score (ICC=0.89). Baseline estimated glomerular filtration rate (eGFR), 24-hour proteinuria, and treatment with immunosuppression were the main determinants of kidney failure in a model with only clinical variables. Only tubular atrophy and interstitial fibrosis were identified as predictors in a model with histological variables. When the total activity score and total chronicity score were added to the model, only the latter was identified as an independent predictor of kidney failure., Limitations: Only a subset of the kidney biopsies was centrally reviewed. Residual confounding., Conclusions: We validated the performance of C3G-HI as a predictor of kidney failure in patients with C3G. The total chronicity score was the principal histologic correlate of kidney failure., Work in this study was supported by the Instituto de Salud Carlos III /Fondo Europeo de Desarrollo Regional (ISCIII/FEDER) grant PI16/01685 and Red de Investigación Renal (RedInRen) (RD12/0021/0029) (to MP), the Autonomous Region of Madrid (S2017/BMD-3673) (to MP); EGdeJ is supported by the Spanish “Ministerio de Ciencia, Innovación y Universidades" (RYC-2013-13395 and RTI2018-095955-B-100).
- Published
- 2021
243. New craniodental material of the extinct sigmodontine Olympicomys (Rodentia, Cricetidae) allows a discussion of its tribal affiliation
- Author
-
Ulyses F.J. Pardiñas, Matias Taglioretti, Franck Barbiere, and Pablo E. Ortiz
- Subjects
Sigmodontinae ,Geography ,Taxon ,biology ,Pleistocene ,Zoology ,General Agricultural and Biological Sciences ,biology.organism_classification ,Cricetidae - Abstract
We re-evaluate the tribal allocation of Olympicomys vossi, an extinct member of Sigmodontinae (Rodentia, Cricetidae). Originally described from fragmentary jaws, this taxon was considered as a Phyllotini. In light of new remains, including hemimandibles and for the first time an anterior part of the cranium with the upper dentition, we propose that it belongs to the Reithrodontini. The studied materials were collected in coastal outcrops of the Vorohu�� Formation (late Pliocene-early Pleistocene) south of Mar del Plata, Buenos Aires Province, Central Argentina. The reallocation of Olympicomys into Reithrodontini is based on the presence in this genus of several diagnostic characters of this tribe including a deeply excised anterior border of the zygomatic plate, a well-developed zygomatic spine, a shallow area of insertion of the anterior deep masseter muscle, a posteriorly depressed palate, labial accessory roots on upper and lower first molars, three-rooted lower third molar, and a bifid metaflexus on the second upper molar. Chukimys favaloroi and Dankomys vorohuensis, two other Pliocene Argentinean sigmodontines, are suggested as extinct reithrodontines. The restudy of Olympicomys provides elements to discuss the pattern of radiation of Sigmodontinae and to improve the chronostratigraphy of the coastal Neogene sedimentary succession of the Buenos Aires province.
- Published
- 2021
- Full Text
- View/download PDF
244. EORTC-QLQ-C30 and SKINDEX-29 measurement of health-related quality of life in patients with mycosis fungoides and Sézary syndrome: real-world data in Spanish patients (MICADOS study)
- Author
-
María del Mar Onteniente Gomis, Belén Navarro Matilla, Ramón María Pujol Vallverdú, Andrea Combalia Escudero, Irma Zapata Paz, Eva González Barca, Cristina Muniesa Montserrat, Mercedes Morillo Andújar, Amparo Pérez Ferriols, Concepción Román Curto, Ricardo Fernández de Misa Cabrera, Mercedes Hospital Gil, Ana Marín Niebla, Pablo Jesús Rios Rull, Fátima De la Cruz Vicente, Rosa María Izu Belloso, Alejandro Martín García-Sancho, María Elisabet Parera Amer, Raúl Córdoba Mascuñano, María Dolores Ramón Quiles, Ana Saus Carreres, Raquel Del Campo García, Salma Machan, Pablo Viguera Ester, Julia Blanco Garnelo, Begoña Soler López, and Pablo Luis Ortiz Romero
- Subjects
Health related quality of life ,Mycosis fungoides ,Cancer Research ,medicine.medical_specialty ,business.industry ,Eortc qlq c30 ,staging ,medicine.disease ,Dermatology ,Quality of life (healthcare) ,Oncology ,quality of life ,Sézary syndrome ,medicine ,In patient ,business ,Real world data - Published
- 2021
245. Crossover and rechallenge with pembrolizumab in recurrent patients from the EORTC 1325-MG/Keynote-054 phase III trial, pembrolizumab versus placebo after complete resection of high-risk stage III melanoma
- Author
-
Eggermont, Alexander M M, Meshcheryakov, Andrey, Atkinson, Victoria, Blank, Christian U., Mandala, Mario, Long, Georgina V, Barrow, Catherine, Di Giacomo, Anna Maria, Fisher, Rosalie, Sandhu, Shahneen, Kudchadkar, Ragini, Romero, Pablo Luis Ortiz, Svane, Inge Marie, Larkin, James, Puig, Susana, Hersey, Peter, Quaglino, Pietro, Queirolo, Paola, Stroyakovskiy, Daniil, Bastholt, Lars, Mohr, Peter, Hernberg, Micaela, Chiarion-Sileni, Vanna, Strother, Matthew, Hauschild, Axel, Yamazaki, Naoya, van Akkooi, Alexander Cj, Lorigan, Paul, Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Kicinski, Michal, Suciu, Stefan, Robert, Caroline, Eggermont, Alexander M M, Meshcheryakov, Andrey, Atkinson, Victoria, Blank, Christian U., Mandala, Mario, Long, Georgina V, Barrow, Catherine, Di Giacomo, Anna Maria, Fisher, Rosalie, Sandhu, Shahneen, Kudchadkar, Ragini, Romero, Pablo Luis Ortiz, Svane, Inge Marie, Larkin, James, Puig, Susana, Hersey, Peter, Quaglino, Pietro, Queirolo, Paola, Stroyakovskiy, Daniil, Bastholt, Lars, Mohr, Peter, Hernberg, Micaela, Chiarion-Sileni, Vanna, Strother, Matthew, Hauschild, Axel, Yamazaki, Naoya, van Akkooi, Alexander Cj, Lorigan, Paul, Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, Kicinski, Michal, Suciu, Stefan, and Robert, Caroline
- Abstract
Background: In the phase III double-blind European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 trial, pembrolizumab improved recurrence free and distant metastasis-free survival in patients with stage III cutaneous melanoma with complete resection of lymph nodes. In the pembrolizumab group, the incidence of grade I-V and of grade III-V immune-related adverse events (irAEs) was 37% and 7%, respectively. Methods: Patients were randomised to receive intravenous (i.v.) pembrolizumab 200 mg (N = 514) or placebo (N = 505) every 3 weeks, up to 1 year. On recurrence, patients could enter part 2 of the study: pembrolizumab 200 mg i.v. every 3 weeks up to 2 years, for crossover (those who received placebo) or rechallenge (those who had recurrence >6 months after completing 1-year adjuvant pembrolizumab therapy). For these patients, we present the safety profile and efficacy outcomes. Results: At the clinical cut-off (16-Oct-2020), in the placebo group, 298 patients had a disease recurrence, in which 155 (52%) crossed over ('crossover'). In the pembrolizumab group, 297 patients completed the 1-year treatment period; 47 had a recurrence >6 months later, in which 20 (43%) entered the rechallenge part 2 ('rechallenge'). In the crossover group, the median progression-free survival (PFS) was 8.5 months (95% confidence interval [CI] 5.7-15.2) and the 3-year PFS rate was 32% (95% CI 25-40%). Among 80 patients with stage IV evaluable disease, 31 (39%) had an objective response: 14 (18%) patients with complete response (CR) and 17 (21%) patients with partial response. The 2-year PFS rate from response was 69% (95% CI 48-83%). In the rechallenge group, the median PFS was 4.1 months (95% CI 2.6-NE). Among 9 patients with stage IV evaluable disease, 1 had an objective response (CR). Among the 175 patients, 51 (29%) had a grade I-IV irAE and 11 (6%) had a grade III-IV irAE. Conclusions: Pembrolizumab treatment after crossover yielded an overall 3-year PFS ra
- Published
- 2021
246. Endovascular Management of Axillosubclavian Injuries in Puerto Rico: Ten-Year Experience
- Author
-
Fernando L. Joglar, Antonio Arrieta, Raquel Vicario, Maria Lozada, Lourdes Guerrios, Ediel Ramos Melendez, and Pablo Rodriguez Ortiz
- Subjects
Surgery ,Cardiology and Cardiovascular Medicine - Published
- 2022
- Full Text
- View/download PDF
247. A new late Pliocene toad of the genus Rhinella (Bufonidae) from northwestern Argentina
- Author
-
María Laura Ponssa, María Judith Babot, Pablo E. Ortiz, Adriana M. Candela, and Martín O. Pereyra
- Subjects
Geology ,Earth-Surface Processes - Published
- 2022
- Full Text
- View/download PDF
248. Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
- Author
-
H Miles Prince, Youn H Kim, Steven M Horwitz, Reinhard Dummer, Julia Scarisbrick, Pietro Quaglino, Pier Luigi Zinzani, Pascal Wolter, Jose A Sanches, Pablo L Ortiz-Romero, Oleg E Akilov, Larisa Geskin, Judith Trotman, Kerry Taylor, Stephane Dalle, Michael Weichenthal, Jan Walewski, David Fisher, Brigitte Dréno, Rudolf Stadler, Tatyana Feldman, Timothy M Kuzel, Yinghui Wang, Maria Corinna Palanca-Wessels, Erin Zagadailov, William L Trepicchio, Wenwen Zhang, Hui-Min Lin, Yi Liu, Dirk Huebner, Meredith Little, Sean Whittaker, Madeleine Duvic, David Joske, H. Miles Prince, Ian D. Lewis, Constanze Jonak, Franz Trautinger, Oliver Bechter, Dominique Bron, Vladmir Claudio C. de Lima, Jose Antonio Sanches, Richard Klasa, Martine Bagot, Marie Beylot-Barry, Michel D'Incan, Brigitte Dreno, Florent Grange, Jan Nicolay, Marion Wobser, Chalid Assaf, Carmen Loquai, Michele Spina, Alberto Bosi, Pier Paolo Fattori, Aleksandra Grzanka, Andres Lopez-Hernandez, Pablo L. Ortiz-Romero, Jose Juan Rifon Roca, Silvana Novelli Canales, Timothy Illidge, Rod Johnson, Stephen Morris, Pam McKay, Oleg Akilov, Steve Horwitz, Youn H. Kim, Barbara Pro, Timothy Kuzel, Adam Lerner, Herbert Eradat, Lubomir Sokol, David C. Fisher, Sarah Hughey, Prince, H. Mile, Kim, Youn H, Horwitz, Steven M, Dummer, Reinhard, Scarisbrick, Julia, Quaglino, Pietro, Zinzani, Pier Luigi, Wolter, Pascal, Sanches, Jose A, Ortiz-Romero, Pablo L, Akilov, Oleg E, Geskin, Larisa, Trotman, Judith, Taylor, Kerry, Dalle, Stephane, Weichenthal, Michael, Walewski, Jan, Fisher, David, Dréno, Brigitte, Stadler, Rudolf, Feldman, Tatyana, Kuzel, Timothy M, Wang, Yinghui, Palanca-Wessels, Maria Corinna, Zagadailov, Erin, Trepicchio, William L, Zhang, Wenwen, Lin, Hui-Min, Liu, Yi, Huebner, Dirk, Little, Meredith, Whittaker, Sean, and Duvic, Madeleine
- Subjects
medicine.medical_specialty ,Immunoconjugates ,Cutaneous T-cell lymphoma ,Population ,Primary cutaneous anaplastic large cell lymphoma ,030207 dermatology & venereal diseases ,03 medical and health sciences ,0302 clinical medicine ,Quality of life ,immune system diseases ,hemic and lymphatic diseases ,Internal medicine ,Antineoplastic Combined Chemotherapy Protocols ,Clinical endpoint ,Humans ,Medicine ,Brentuximab vedotin ,education ,Brentuximab Vedotin ,Bexarotene ,Mycosis fungoides ,education.field_of_study ,business.industry ,Medicine (all) ,General Medicine ,medicine.disease ,Lymphoma, T-Cell, Cutaneous ,Surgery ,030220 oncology & carcinogenesis ,Quality of Life ,Neoplasm Recurrence, Local ,business ,medicine.drug - Abstract
Cutaneous T-cell lymphomas are rare, generally incurable, and associated with reduced quality of life. Present systemic therapies rarely provide reliable and durable responses. We aimed to assess efficacy and safety of brentuximab vedotin versus conventional therapy for previously treated patients with CD30-positive cutaneous T-cell lymphomas.In this international, open-label, randomised, phase 3, multicentre trial, we enrolled adult patients with CD30-positive mycosis fungoides or primary cutaneous anaplastic large-cell lymphoma who had been previously treated. Patients were enrolled across 52 centres in 13 countries. Patients were randomly assigned (1:1) centrally by an interactive voice and web response system to receive intravenous brentuximab vedotin 1·8 mg/kg once every 3 weeks, for up to 16 3-week cycles, or physician's choice (oral methotrexate 5-50 mg once per week or oral bexarotene 300 mg/mBetween Aug 13, 2012, and July 31, 2015, 131 patients were enrolled and randomly assigned to a group (66 to brentuximab vedotin and 65 to physician's choice), with 128 analysed in the intention-to-treat population (64 in each group). At a median follow-up of 22·9 months (95% CI 18·4-26·1), the proportion of patients achieving an objective global response lasting at least 4 months was 56·3% (36 of 64 patients) with brentuximab vedotin versus 12·5% (eight of 64) with physician's choice, resulting in a between-group difference of 43·8% (95% CI 29·1-58·4; p0·0001). Grade 3-4 adverse events were reported in 27 (41%) of 66 patients in the brentuximab vedotin group and 29 (47%) of 62 patients in the physician's choice group. Peripheral neuropathy was seen in 44 (67%) of 66 patients in the brentuximab vedotin group (n=21 grade 2, n=6 grade 3) and four (6%) of 62 patients in the physician's choice group. One of the four on-treatment deaths was deemed by the investigator to be treatment-related in the brentuximab vedotin group; no on-treatment deaths were reported in the physician's choice group.Significant improvement in objective response lasting at least 4 months was seen with brentuximab vedotin versus physician's choice of methotrexate or bexarotene.Millennium Pharmaceuticals Inc (a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd), Seattle Genetics Inc.
- Published
- 2017
- Full Text
- View/download PDF
249. Obstrucción intestinal secundaria a vólvulo espléndico en un paciente pediátrico
- Author
-
Juan Pablo Murillo-Ortiz and Marco V Vargas-Salas
- Subjects
vólvulo de intestino medio ,vólvulo esplénico ,bazo errante ,Medicine - Abstract
La torsión de un bazo errante es rara. La forma de presentación varia desde dolor abdominal intermitente hasta un cuadro de abdomen agudo. Se presenta un caso clínico de un paciente pediátrico con obstrucción intestinal secundaria a la torsión de un bazo errante
- Published
- 2005
250. Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas
- Author
-
Esperanza Martín-Sánchez, Socorro M. Rodríguez-Pinilla, Margarita Sánchez-Beato, Luis Lombardía, Beatriz Domínguez-González, Diana Romero, Lina Odqvist, Pablo García-Sanz, Magdalena B. Wozniak, Guido Kurz, Carmen Blanco-Aparicio, Manuela Mollejo, F. Javier Alves, Javier Menárguez, Fernando González-Palacios, José Luis Rodríguez-Peralto, Pablo L. Ortiz-Romero, Juan F. García, James R. Bischoff, and Miguel A. Piris
- Subjects
Diseases of the blood and blood-forming organs ,RC633-647.5 - Abstract
Peripheral T-cell lymphomas are very aggressive hematologic malignancies for which there is no targeted therapy. New, rational approaches are necessary to improve the very poor outcome in these patients. Phosphatidylinositol-3-kinase is one of the most important pathways in cell survival and proliferation. We hypothesized that phosphatidylinositol-3-kinase inhibitors could be rationally selected drugs for treating peripheral T-cell lymphomas. Several phosphatidylinositol-3-kinase isoforms were inhibited genetically (using small interfering RNA) and pharmacologically (with CAL-101 and GDC-0941 compounds) in a panel of six peripheral and cutaneous T-cell lymphoma cell lines. Cell viability was measured by intracellular ATP content; apoptosis and cell cycle changes were checked by flow cytometry. Pharmacodynamic biomarkers were assessed by western blot. The PIK3CD gene, which encodes the δ isoform of phosphatidylinositol-3-kinase, was overexpressed in cell lines and primary samples, and correlated with survival pathways. However, neither genetic nor specific pharmacological inhibition of phosphatidylinositol-3-kinase δ affected cell survival. In contrast, the pan-phosphatidylinositol-3-kinase inhibitor GDC-0941 arrested all T-cell lymphoma cell lines in the G1 phase and induced apoptosis in a subset of them. We identified phospho-GSK3β and phospho-p70S6K as potential biomarkers of phosphatidylinositol-3-kinase inhibitors. Interestingly, an increase in ERK phosphorylation was observed in some GDC -0941-treated T-cell lymphoma cell lines, suggesting the presence of a combination of phosphatidylinositol-3-kinase and MEK inhibitors. A highly synergistic effect was found between the two inhibitors, with the combination enhancing cell cycle arrest at G0/G1 in all T-cell lymphoma cell lines, and reducing cell viability in primary tumor T cells ex vivo. These results suggest that the combined treatment of pan-phosphatidylinositol-3-kinase + MEK inhibitors could be more effective than single phosphatidylinositol-3-kinase inhibitor treatment, and therefore, that this combination could be of therapeutic value for treating peripheral and cutaneous T-cell lymphomas.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.